Multiple myeloma

Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For National Cancer Survivor Month, we share his incredible story.

Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson’s venture capital division, which invests in dozens of companies each year. He shares what’s on his radar for 2019.

Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.

Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she and other scientists are working to someday make this cutting-edge concept a reality.